2-(3-Pyridinyl)-4-thiazolecarboxylic acid (ACI)

2-[[(3′-Butoxy-3-chloro-5-fluoro[1,1′-biphenyl]-4-yl)amino]carbonyl]benzoic acid (ACI)

2-[3,6-Bis(acetyloxy)-9H-xanthen-9-yl]benzoic acid (ACI)

5-(4-Fluorophenyl)-2-methyl-3-furancarboxylic acid (ACI)

2-[(Phenylsulfinyl)methyl]benzoic acid (ACI)

3-[[[3-[[3-[4-(4-Morpholinyl)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]amino]phenyl]methyl]thio]benzoic acid (ACI)

2-Methyl-5-(4-methylphenyl)-3-furancarboxylic acid (ACI)

DNA d(P-thio)(T-C-C-A-T-G-A-C-G-T-T-C-C-T-G-A-T-G-C-T) (ACI)

Onartuzumab

Ixekizumab

Immunoglobulin G4, anti-(human protein VAP-1 (vascular adhesion protein 1)) (human monoclonal BTT-1023 γ4-chain), disulfide with human monoclonal BTT-1023 κ-chain, dimer (ACI)

DNA d(P-thio)([2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rU-m5C-T-T-G-T-m5C-m5C-A-G-m5C-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]m5rU) (ACI)

TGN 1412 (9CI, ACI)

Obinutuzumab

Romosozumab

Vedolizumab

Drozitumab

Lirilumab

Olokizumab

Etrolizumab